A Novel Compound, Tanshinol Borneol Ester, Ameliorates Pressure Overload-Induced Cardiac Hypertrophy by Inhibiting Oxidative Stress via the mTOR/β-TrCP/NRF2 Pathway

Overview of attention for article published in Frontiers in Pharmacology, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Nrf2 mediated signaling axis in heart failure: Potential pharmacological receptor

Article in Pharmacological Research (June 2024)

HAPLN1 knockdown inhibits heart failure development via activating the PKA signaling pathway

Article in BMC Cardiovascular Disorders (April 2024)

Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?

Article in European Journal of Heart Failure (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.